Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Nevada for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Nevada only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Nevada (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Hardeep Dhindsa (NPI 1366402570)

Field	Value
Entity Type	Individual
Organization	Hardeep Dhindsa
Address	5449 Reno Corporate Dr Ste 200
City	Reno
State	NV
ZIP	89511
Taxonomy	Ophthalmology Physician
NPI Enumerated	March 23, 2006

Payer Source	Total Paid
Medicare	$1.8M
Medicaid	$0

Key Findings

This provider is effectively a single‑payer Medicare practice: Total Medicare revenue: $1.8M and Total Medicaid revenue: none (no Medicaid billing on file). The provider’s NPI was enumerated on 2006-03-23 (~20 years ago), indicating long tenure in the market but no recorded Medicaid activity to diversify payer exposure. This concentrated payer mix makes the practice highly sensitive to Medicare policy and reimbursement changes affecting ophthalmology services.

Revenue is highly concentrated in a small set of services: the precomputed top 3 Medicare codes by revenue account for 72.1% of this provider's total Medicare revenue, led by J0178 (56.9%). J0178 alone accounts for $1M of Medicare revenue (1.5K claims, $692 avg paid/claim), and the next two contributors are 99214 ($175.2K; 2K claims) and 92134 ($92.2K; 3.2K claims). This concentration highlights dependence on intravitreal drug therapy and associated office-based evaluation and retinal imaging.

The code mix and volumes indicate an ambulatory retina-focused practice that combines high-volume injection therapy with substantial diagnostic imaging and office visits. The dominance of J0178 (Injection, aflibercept) plus high counts for 92134 (3.2K claims, $29 avg, $92.2K revenue) and 92250 (1.9K claims, $28 avg, $54.1K revenue) point to a workflow centered on recurring intravitreal injections supported by on‑site retinal imaging and fundus photography. Procedural codes for isolated intravitreal injection (67028: 888 claims, $78.1K) and some surgical retinal procedures are present but represent a smaller share of revenue compared with injections and imaging.

Competitive standing is mixed by service line: for intravitreal aflibercept (J0178) the provider ranks #856 of 3204 providers nationally (73th percentile; typical, unremarkable volume for this code), so drug administration volume is within a typical peer range. By contrast, the provider is an extreme outlier on visit and imaging volumes—99214 ranks #1395 of 479517 providers nationally (100th percentile; extreme outlier, far above typical national volume for this code) and 92134 ranks #333 of 26868 providers nationally (99th percentile; extreme outlier). In short, the practice shows unusually high ambulatory visit and imaging throughput even if its aflibercept volume is not exceptional among injection providers.

Several other codes reinforce the in‑office, high‑throughput retina profile and suggest breadth of drug use beyond aflibercept. J2777 (faricimab) appears with 1.9K claims and $53.8K revenue but ranks #1973 of 2039 providers nationally (3th percentile; typical, unremarkable volume for this code), while J2781 (pegcetacoplan) shows 345 claims and $41.4K revenue (rank #379 of 490; 21th percentile). J3490 (unclassified drugs) is a smaller but notable revenue contributor ($37K from 21 claims at $1764 avg paid/claim), indicating occasional billing for non‑standard drug supplies or drugs billed under a miscellaneous HCPCS.

The provider bills very high volumes of both new and established E/M codes relative to national peers, suggesting a high patient throughput and possibly more complex ambulatory management. Examples include 99214 (2K claims, $175.2K revenue; extreme outlier) and 99204 (345 claims, $38.6K revenue; ranks #794 of 227068 providers nationally; 100th percentile; extreme outlier), alongside elevated volumes for 99213, 99203, and 99215. This pattern has operational implications for staffing, scheduling, and revenue cycle management focused on repeat visits for chronic retinal disease.

Surgical retina procedures are present but represent a small portion of billed revenue, implying the practice is not primarily surgical or that surgery is a secondary service line. Codes such as 67042 (29 claims, $26.1K), 67108 (16 claims, $14.1K), and 67036 (17 claims, $12.1K) appear at modest volumes and generally rank in typical national percentiles rather than as outliers. For payer contracting or network planning, the practice should be viewed primarily as an outpatient retina/injection and imaging center with limited inpatient or high‑revenue surgical retina activity.

From a risk and contracting perspective, the combination of heavy reliance on J0178 ($1M revenue) and extreme outlier volumes for office visits and imaging concentrates financial exposure in repeat, chronic‑care workflows (injections plus surveillance imaging). The absence of Medicaid billing removes a contracting lever for state programs and suggests commercial payers and Medicare will be the primary negotiation counterparts. Analytics teams should monitor utilization trends for J0178, 99214, and 92134 (the top 3 codes) given they collectively account for 72.1% of Medicare revenue and thus drive the bulk of this provider’s reimbursement profile.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

25 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	1,450	$690	$1M
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	1,970	$90	$175.2K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	3,180	$30	$92.2K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	890	$90	$78.1K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	950	$60	$60.1K
92250	Code 92250 describes the taking of fundus photographs, that is, photographs of the posterior segment of the inner aspect of the eye, to document alterations in the optic nerve head, retinal vessels,…	1,930	$30	$54.1K
J2777	Injection, faricimab‑svoa, 0.1 mg	1,920	$30	$53.8K
J2781	Injection, pegcetacoplan, intravitreal, 1 mg	350	$120	$41.4K
99204	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider…	350	$110	$38.6K
J3490	Unclassified drugs	20	$1,760	$37K

Showing 1–10 of 25

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 25 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Nevada Distribution

Hardeep Dhindsa — 5 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Nevada

Full comparison — all codes billed, vs. state median

25 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	5	20	830	$690	$671.6K
J2777	13	10	7,020	$30	$616.8K
67028	8	30	670	$90	$72.3K
J7312	6	10	380	$160	$68.5K
J2781	2	10	560	$120	$66.8K
67108	4	10	20	$1,100	$24.3K
67036	4	10	30	$950	$20.8K
67042	2	10	20	$1,090	$20.7K
99214	15	3,610	110	$80	$19K
J9035	16	20	230	$50	$15.6K

Showing 1–10 of 25

Related Providers

Other providers that share a Tax Identification Number (TIN) with Hardeep Dhindsa, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Stephanie Vanderveldt	GA	Ophthalmology Physician	$4.1M	$0
Sri Krishna Mukkamala	GA	Hospitalist Physician	$3.4M	$0
Alexander Bottini	GA	Retina Specialist (Ophthalmology) Physician	$3M	$0
David Chin Yee	GA	Retina Specialist (Ophthalmology) Physician	$2.9M	$0
Gregory Lee	GA	Ophthalmology Physician	$2.9M	$6.3K
Robert Stoltz	GA	Specialist	$2.6M	$0
Hyung Cho	GA	Ophthalmology Physician	$2.5M	$0
Sean Koh	GA	Ophthalmology Physician	$2.5M	$0
Atul Sharma	GA	Ophthalmology Physician	$2.2M	$0
Mark Rivellese	GA	Ophthalmology Physician	$2.1M	$0

Nearby Providers

Other providers in the same ZIP code as Hardeep Dhindsa, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Kuhn Physical Therapy LLC	NV	Physical Therapist	$0	$13.1M
Elena Geraymovych	NV	Ophthalmology Physician	$4.1M	$16.9K
Routt Dialysis LLC	NV	End-Stage Renal Disease (ESRD) Treatment Clinic/Center	$0	$3.6M
Nevada Emergency Physicians PLLC	NV	Emergency Medicine Physician	$0	$3.3M
Eye Surgery Center Of Northern Nevada, LLC	NV	Ambulatory Surgical Clinic/Center	$2.7M	$114.7K
Steven Friedlander	NV	Ophthalmology Physician	$2.4M	$376.5K
Culpepper Psychiatric Associates PLLC	NV	Community Health Clinic/Center	$0	$2.6M
Tejvir Singh	NV	Hematology & Oncology Physician	$2.5M	$280
Liberty Dialysis-south Reno LLC	NV	End-Stage Renal Disease (ESRD) Treatment Clinic/Center	$0	$2.5M
Saint Marys Urgent Care LLC	NV	Multi-Specialty Clinic/Center	$0	$2.3M

Hardeep Dhindsa — Billing Profile & Reimbursement Data

Sign up for Hardeep Dhindsa — Billing Profile & Reimbursement Data policy alerts

Hardeep Dhindsa — Billing Profile & Reimbursement Data

Sign up for Hardeep Dhindsa — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References